Email Page Print Page

SEC Filings and Financial Information

NASDAQBDSI
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMar 12, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 21, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 21, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 21, 2014View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2014View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2014View HTMLDownload DOCDownload PDF
5Annual filing director officer or owner of more than ten percent.Feb 14, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 28, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 28, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 28, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 28, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 28, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 17, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 10, 2014View HTMLDownload DOCDownload PDF
1-25      26-39
Top News
Nov 16, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that Dr. Mark A. Sirgo, Vice...

Nov 9, 2017

BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and nine months ended September 30, 2017, and provided an update on recent business highlights and...

Oct 30, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its third quarter 2017 financial results and host a conference call and webcast at 4:30 PM Eastern Time on...

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com